https://www.selleckchem.com/products/ars-853.html
8% to -4.7%, p0.05) after the North Carolina STOP Act (9.8% to 6.5%; 95% CI 5.5% to 7.5%, p0.05). There was no statistically significant change in the prescribing of codeine syrup for 5 days pre-STOP and post- STOP Act, respectively (91.5% and 90.4%; difference=-1.1%, p=0.83). The North Carolina STOP Act was associated with a reduction in the overall percentage of opioid prescriptions for 5 days for acute pain/non-pain diagnoses. However, there was no statistically significant effect on the prescribing of codeine-contain